Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

2020402 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 21, Issue 7, pp. 923-934

Field-Weighted Citation Impact: 39.52